News

Despite advances, the roles of genetics and microenvironment in CLL are not fully understood, and curative treatments may hinge on a dual approach targeting both.
CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...
Tumors are complex systems characterized by variations across genetic, transcriptomic, phenotypic, and microenvironmental ...
Combination therapy of osimertinib and datopotamab deruxtecan shows promising efficacy in advanced NSCLC, warranting further ...
CHAF1B, a histone chaperone component of the chromatin assembly factor-1 complex, is overexpressed in multiple cancers and ...
Tumors are complex systems characterized by variations across genetic, transcriptomic, phenotypic, and microenvironmental ...
The FDA granted priority review to the combination of lurbinectedin and atezolizumab as a first-line maintenance therapy for ...
Results show the regimen of epcoritamab plus R-ICE could serve most patients as a bridge to either autologous stem cell ...